-
Something wrong with this record ?
Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade
Y. Mytsyk, I. Dutka, Y. Borys, I. Komnatska, I. Shatynska-Mytsyk, AA. Farooqi, K. Gazdikova, M. Caprnda, L. Rodrigo, P. Kruzliak,
Language English Country Netherlands
Document type Journal Article
NLK
ProQuest Central
from 1999-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2011-03-01 to 1 year ago
Health & Medicine (ProQuest)
from 1999-01-01 to 1 year ago
- MeSH
- Diagnosis, Differential MeSH
- Diffusion Magnetic Resonance Imaging methods MeSH
- Adult MeSH
- Carcinoma, Renal Cell * diagnosis pathology MeSH
- Kidney * diagnostic imaging pathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Dimensional Measurement Accuracy MeSH
- Prognosis MeSH
- Reproducibility of Results MeSH
- Aged MeSH
- Neoplasm Staging MeSH
- Neoplasm Grading MeSH
- Patient Selection MeSH
- Quality Improvement MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Renal cell carcinoma (RCC) represents the most common malignant epithelial neoplasm of the kidney. Accurate assessment of the renal masses, defining the histologic subtype and the grade of differentiation of the tumor, is vital to ensure an adequate case management as well as for staging and prognosis. Recently, diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) tends to be increasingly appealing for the clinicians as an imaging procedure of choice for the diagnosis and staging of the RCC, which is predetermined by several advantages over CT. The goal of the survey was to assess the applicability of the apparent diffusion coefficient (ADC) of the DWI MRI for the differential diagnostics, histologic subtyping, and defining the grade of differentiation of the RCC. METHODS: The study enrolled 288 adult patients with renal lesions: 188 patients with solid RCC-126 patients with clear cell subtype (ccRCC), 32 patients with papillary RCC (pRCC), 30 patients with chromophobe RCC (chRCC); 27 patient with cystic form or RCC (Bosniak cyst, category IV); 32 patients with renal angiomyolipoma (AML); 25 patients with renal oncocytoma (OC); and 16 patients with the renal abscess (AB). In total, 245 lesions were pathologically verified. As a reference, 19 healthy volunteers were included into the study. All patients underwent MRI of the kidneys, involving DWI with subsequent evaluation of the ADC. RESULTS: There was a reliable difference (p < 0.05) in mean ADC values between the normal renal parenchyma (NRP), solid RCC of different histologic subtypes and grades, cystic RCC, and benign renal lesions. The mean ADC values obtained in the result of the study were (×10(-3) mm(2)/s): 2.47 ± 0.12 in NRP, 1.63 ± 0.29 in all solid RCCs, 1.82 ± 0.22 in solid ccRCC (1.92 ± 0.11-Fuhrman grade I, 1.84 ± 0.14-Fuhrman grade II, 1.79 ± 0.10-Fuhrman grade III, 1.72 ± 0.06-Fuhrman grade IV), 1.61 ± 0.07 in pRCC, 1.46 ± 0.09 in chRCC, 2.68 ± 0.11 in cystic RCC, 2.13 ± 0.08 in AML, 2.26 ± 0.06 in OC, and 3.30 ± 0.07 in AB. CONCLUSION: The data received in our study demonstrate a substantial restriction of diffusion of hydrogen molecules in tissues of ccRCC in comparison with the healthy renal parenchyma preconditioned by the greater density of tumor. A statistically significant difference in mean ADC values of ccRCC with different grades of nuclear pleomorphism by Fuhrman was observed: Low-grade tumors showed higher mean ADC values compared to high-grade tumors. The modality of the MRI DWI along with ADC measurement allows to reliably differentiate between the solid RCC of main histologic subtypes and grades, cystic RCC, and the benign renal lesions.
Department of Radiology Lviv National Medical University Lviv Ukraine
Department of Urology Lviv National Medical University Pekarska str 69 Lviv Ukraine
Euroclinic Medical Center Lviv Ukraine
University of Oviedo Central University Hospital of Asturias Oviedo Spain
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17031288
- 003
- CZ-PrNML
- 005
- 20171030131943.0
- 007
- ta
- 008
- 171025s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11255-016-1460-3 $2 doi
- 035 __
- $a (PubMed)27853915
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Mytsyk, Yulian $u Department of Urology, Lviv National Medical University, Pekarska str. 69, Lviv, Ukraine. mytsyk.yulian@i.ua.
- 245 10
- $a Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade / $c Y. Mytsyk, I. Dutka, Y. Borys, I. Komnatska, I. Shatynska-Mytsyk, AA. Farooqi, K. Gazdikova, M. Caprnda, L. Rodrigo, P. Kruzliak,
- 520 9_
- $a BACKGROUND: Renal cell carcinoma (RCC) represents the most common malignant epithelial neoplasm of the kidney. Accurate assessment of the renal masses, defining the histologic subtype and the grade of differentiation of the tumor, is vital to ensure an adequate case management as well as for staging and prognosis. Recently, diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) tends to be increasingly appealing for the clinicians as an imaging procedure of choice for the diagnosis and staging of the RCC, which is predetermined by several advantages over CT. The goal of the survey was to assess the applicability of the apparent diffusion coefficient (ADC) of the DWI MRI for the differential diagnostics, histologic subtyping, and defining the grade of differentiation of the RCC. METHODS: The study enrolled 288 adult patients with renal lesions: 188 patients with solid RCC-126 patients with clear cell subtype (ccRCC), 32 patients with papillary RCC (pRCC), 30 patients with chromophobe RCC (chRCC); 27 patient with cystic form or RCC (Bosniak cyst, category IV); 32 patients with renal angiomyolipoma (AML); 25 patients with renal oncocytoma (OC); and 16 patients with the renal abscess (AB). In total, 245 lesions were pathologically verified. As a reference, 19 healthy volunteers were included into the study. All patients underwent MRI of the kidneys, involving DWI with subsequent evaluation of the ADC. RESULTS: There was a reliable difference (p < 0.05) in mean ADC values between the normal renal parenchyma (NRP), solid RCC of different histologic subtypes and grades, cystic RCC, and benign renal lesions. The mean ADC values obtained in the result of the study were (×10(-3) mm(2)/s): 2.47 ± 0.12 in NRP, 1.63 ± 0.29 in all solid RCCs, 1.82 ± 0.22 in solid ccRCC (1.92 ± 0.11-Fuhrman grade I, 1.84 ± 0.14-Fuhrman grade II, 1.79 ± 0.10-Fuhrman grade III, 1.72 ± 0.06-Fuhrman grade IV), 1.61 ± 0.07 in pRCC, 1.46 ± 0.09 in chRCC, 2.68 ± 0.11 in cystic RCC, 2.13 ± 0.08 in AML, 2.26 ± 0.06 in OC, and 3.30 ± 0.07 in AB. CONCLUSION: The data received in our study demonstrate a substantial restriction of diffusion of hydrogen molecules in tissues of ccRCC in comparison with the healthy renal parenchyma preconditioned by the greater density of tumor. A statistically significant difference in mean ADC values of ccRCC with different grades of nuclear pleomorphism by Fuhrman was observed: Low-grade tumors showed higher mean ADC values compared to high-grade tumors. The modality of the MRI DWI along with ADC measurement allows to reliably differentiate between the solid RCC of main histologic subtypes and grades, cystic RCC, and the benign renal lesions.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a karcinom z renálních buněk $x diagnóza $x patologie $7 D002292
- 650 _2
- $a diferenciální diagnóza $7 D003937
- 650 _2
- $a difuzní magnetická rezonance $x metody $7 D038524
- 650 _2
- $a přesnost dimenzionálního měření $7 D061827
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a ledviny $x diagnostické zobrazování $x patologie $7 D007668
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a stupeň nádoru $7 D060787
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a výběr pacientů $7 D018579
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a zlepšení kvality $7 D058996
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dutka, Ihor $u Euroclinic Medical Center, Lviv, Ukraine.
- 700 1_
- $a Borys, Yuriy $u Department of Urology, Lviv National Medical University, Pekarska str. 69, Lviv, Ukraine.
- 700 1_
- $a Komnatska, Iryna $u Euroclinic Medical Center, Lviv, Ukraine.
- 700 1_
- $a Shatynska-Mytsyk, Iryna $u Department of Radiology, Lviv National Medical University, Lviv, Ukraine.
- 700 1_
- $a Farooqi, Ammad Ahmad $u Laboratory of Translational Oncology and Personalized Medicine, Rashid Latif Medical College, Lahore, Pakistan.
- 700 1_
- $a Gazdikova, Katarina $u Department of Nutrition, Faculty of Nursing and Professional Health Studies, Slovak Medical University, Limbova 12, 833 03, Bratislava, Slovak Republic. katarina.gazdikova@szu.sk. Department of General Medicine, Faculty of Medicine, Slovak Medical University, Bratislava, Slovak Republic. katarina.gazdikova@szu.sk.
- 700 1_
- $a Caprnda, Martin $u University of Oviedo, Central University Hospital of Asturias (HUCA), Oviedo, Spain.
- 700 1_
- $a Rodrigo, Luis $u University of Oviedo, Central University Hospital of Asturias (HUCA), Oviedo, Spain.
- 700 1_
- $a Kruzliak, Peter $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho tr 1946/1, 612 42, Brno, Czech Republic. kruzliakpeter@gmail.com. 2nd Department of Surgery, Faculty of Medicine, Masaryk University, Brno, Czech Republic. kruzliakpeter@gmail.com.
- 773 0_
- $w MED00002396 $t International urology and nephrology $x 1573-2584 $g Roč. 49, č. 2 (2017), s. 215-224
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27853915 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171030132032 $b ABA008
- 999 __
- $a ok $b bmc $g 1254881 $s 992315
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 49 $c 2 $d 215-224 $e 20161116 $i 1573-2584 $m International urology and nephrology $n Int Urol Nephrol $x MED00002396
- LZP __
- $a Pubmed-20171025